A recent study published in Nature reports that metformin and dextromethorphan, two drugs already in use to treat other diseases, […]
Scientists have identified a potential new treatment approach for a rare genetic disorder known as Hutchinson-Gilford progeria syndrome (HGPS). Hutchinson-Gilford […]
Researchers have performed a comprehensive genetic analysis and identified potential drug targets for paediatric germ cell tumours (GCTs). Germ cell […]
An understanding of the environmental and genetic risk of Alzheimer’s Disease is vital for the production of more effective therapies. […]
Front Line Genomics is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on […]
Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]
A study conducted by a team at UCL identified potential drug and vaccine targets for SARS-CoV-2. The results of the […]
A recent study, published in The American Journal of Psychiatry, has shed light on the mechanisms behind the brain’s response to stress in those with post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). The implications of this study are far-reaching, from improving our understanding of the cellular and molecular basis of PTSD and MDD to potentially revolutionizing the diagnosis and treatment of these challenging neuropsychiatric disorders. The findings open up exciting avenues for further research, personalized medicine, and the development of targeted therapeutic interventions.
At the Festival of Genomics and Biodata, we are lucky enough to be joined by some of the biggest names […]
At the Festival of Genomics and Biodata, we are lucky enough to be joined by some of the biggest names […]
